About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%

NCT00827255·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Allergan

Age

16–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Adults \>16 years of age
Dry eye patients
Subject with history of less than 12 weeks of initial RESTASIS® treatment
Subject started second trial of RESTASIS® treatment prior to June 1, 2008
First day of second trial of RESTASIS® started ≥ 4 weeks after the last day of previous RESTASIS® treatment

You may not be if

Patients with Contact Lens Intolerance
Patients with Ocular Rosacea

The record

StatusCompleted

PhaseNo phase

Taking part35

StartedJan 2009

UpdatedApr 25, 2019

Conditions

Dry Eye Disease

Where1

Pittsburgh, Pennsylvania, United States

Clareo Health | Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%